Filter
894
Filtered Results: 894
Text search:
preventive
chemotherapy
Featured
Recommendations
121
New Publications
208
Language
Document type
No document type
421
Studies & Reports
167
Guidelines
165
Manuals
50
Strategic & Response Plan
34
Fact sheets
24
Training Material
11
Situation Updates
6
Resource Platforms
5
Brochures
3
Dashboards/Maps
3
Online Courses
3
Infographics
2
Countries / Regions
India
77
Global
38
Kenya
22
Western and Central Europe
22
South Africa
22
Uganda
18
Africa
16
Ethiopia
16
Tanzania
14
Eastern Europe
14
Nepal
10
Germany
10
Zambia
10
Ghana
9
Malawi
9
Nigeria
8
Philippines
8
Bangladesh
8
Rwanda
7
Latin America and the Carribbean
7
Botswana
7
Myanmar / Burma
7
Brazil
6
Russia
6
Lesotho
5
Sierra Leone
5
Syria
5
Namibia
5
Ukraine
4
Mozambique
4
Cambodia
4
Venezuela
4
South–East Asia Region
4
Sudan
4
Indonesia
4
Eswatini/ Swaziland
4
USA
3
Asia
3
Middle East and North Africa
3
East and Southern Africa
3
Colombia
2
Thailand
2
Cameroon
2
Laos
2
Afghanistan
2
Zimbabwe
2
Qatar
2
Saudi Arabia
2
West and Central Africa
2
Paraguay
2
Argentina
2
Vietnam
2
Yemen
2
Libya
2
South Sudan
2
Iraq
2
Somalia
2
Ecuador
2
Pakistan
2
Timor Leste/ East Timor
1
Benin
1
Gambia
1
Iran
1
Senegal
1
Peru
1
Jordan
1
Congo, Democratic Republic of
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Mauritius
1
Israel
1
Lebanon
1
Djibouti
1
Egypt
1
Palestine
1
Georgia
1
Bhutan
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
307
Clinical Guidelines
154
Public Health
50
Women & Child Health
33
Key Resources
28
Capacity Building
9
Pharmacy & Technologies
8
Toolboxes
TB
145
NTDs
143
AMR
64
COVID-19
46
Caregiver
34
Pharmacy
31
HIV
24
Rapid Response
17
Refugee
16
Planetary Health
12
Ebola & Marburg
10
NCDs
10
Mental Health
9
Polio
9
Conflict
8
Global Health Education
6
Specific Hazards
4
Malaria
3
Natural Hazards
2
Disability
2
Cholera
2
Zika
2
Social Ethics
1
Health Financing Toolbox
1
Las infecciones del sitio quirúrgico (ISQ) constituyen una de las Infecciones Asociadas al Cuidado de la Salud (IACS) más frecuentes que ponen en riesgo a los pacientes llevando muchas veces al fracaso del procedimiento quirúrgico. Con una incidencia mucho mayor en países de medianos y bajos ing...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug...
Manual para directores de programas
Mycetoma is a specific chronic, granulomatous, inflammatory disease. It usually involves the subcutaneous tissue, most probably after traumatic inoculation of the causative organism. It has a prolonged, progressive, and indolent course, and, if untreated, it ultimately leads to destruction of the de...
A new publication - Waste Management during the COVID-19 Pandemic: from response to recovery - reviews current practices for managing waste from healthcare facilities, households and quarantine locations accommodating people with confirmed or suspected cases of COVID-19. Jointly produced by UNEP, th...
El agente etiológico de la tuberculosis es el Mycobacterium tuberculosis o bacilo de Koch. Se trata de un bacilo aerobio estricto, ácido-alcohol resistente, sin movilidad, de crecimiento lento y que se inactiva con rayos ultravioleta y temperaturas mayores de 60°C.
This Tuberculosis guide has been developed jointly by Médecins Sans Frontières and Partners In Health. It aims at providing useful information to the clinicians and health staff for the comprehensive management of tuberculosis. Forms of susceptible and resistant tuberculosis, tuberculosis in child...
La publicación describe el funcionamiento del método rápido, confiable, sencillo y económico al laboratorio que permita examinar un gran número de muestras a fin de seleccionar a aquellos pacientes que pudieran estar potencialmente infectados con Mycobacterium tuberculosis multirresistente a lo...
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf...
The report presents the latest data on more than 50 health-related Sustainable Development Goal and "triple billion" target indicators. The 2021 edition includes preliminary estimates for global excess deaths attributable to COVID-19 for 2020 and the state of global and regional health trends from 2...
Noma (cancrum oris) is a severe gangrenous disease of the mouth and face. It mostly affects children between the ages of 2 and 6 years living in extreme poverty. In addition to the known factors such as malnutrition, lack of vaccination in children and poor oral hygiene, several social and environme...
In 2011, ICTC developed a Trachoma Action Plan (TAP) planning guide to support national health officials in endemic countries. This resource was developed to complement the 2020 INSight roadmap by helping countries create specific national plans detailing how they will reach elimination targets in t...
Le Cadre d’action régional vise à aider les États Membres, l’OMS et tous les autres donateurs et partenaires à travailler ensemble pour remédier systématiquement et progressivement aux diverses faiblesses relevées dans les principaux domaines programmatiques et/ou de contribuer à renforc...
This updated step by step guide aims to assist the ministries of health (MoHs) in developing the national action plans for noma prevention and control, with a view to sustainably reducing the incidence of noma as a public health problem through programmes that are fully integrated with national heal...
WHO today published the new edition of its Model Lists of Essential Medicines and Essential Medicines for Children, which include new treatments for various cancers, insulin analogues and new oral medicines for diabetes, new medicines to assist people who want to stop smoking, and new antimicrobials...
